Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin

Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin

US Patent 10912823 · Granted Feb 9, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors2023
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and2022
Botulinum toxin cell binding domain polypeptides and methods of use for skin rej2021
Botulinum toxin cell binding domain polypeptides and methods of use for skin rej2021
Microneedle array with active ingredient2021
Compounds supports hematopoietic stem cells and red blood cells2021
Immuno-based retargeted endopeptidase activity assays2021
Biomass-based high-efficiency fluorescent graphene quantum dot and preparation m2020
Immuno-based botulinum toxin serotype A activity assays2020
Non-cytotoxic protein conjugates2020